Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
UBS
Medtronic
Moodys
McKesson
Fish and Richardson
Cantor Fitzgerald
AstraZeneca
Express Scripts

Generated: June 18, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 080025

« Back to Dashboard

NDA 080025 describes SULF-10, which is a drug marketed by Novartis and is included in one NDA. Additional details are available on the SULF-10 profile page.

The generic ingredient in SULF-10 is sulfacetamide sodium. There are three drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the sulfacetamide sodium profile page.
Summary for 080025
Tradename:SULF-10
Applicant:Novartis
Ingredient:sulfacetamide sodium
Patents:0
Therapeutic Class:Antibacterials
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 080025

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:SOLUTION/DROPS;OPHTHALMICStrength10%
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Harvard Business School
Express Scripts
Argus Health
Farmers Insurance
QuintilesIMS
Dow
Chinese Patent Office
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.